Ilya Rachman's Insider Trades & SAST Disclosures
Ilya Rachman's most recent trade in Immix Biopharma Inc was a trade of 340,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ilya Rachman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 340,000 | 340,000 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 07 Jun 2024 | 2,600 | 1,136,259 | - | 2.1 | 5,538 | Common Stock |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 1.81 per share. | 04 Jun 2024 | 3,300 | 1,133,659 | - | 1.8 | 5,970 | Common Stock |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 218,359 | 1,130,359 | - | - | Common Stock | |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 14 May 2024 | 4,300 | 912,000 | - | 2.2 | 9,660 | Common Stock |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 193,000 | 193,000 | - | - | Stock Options | |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 14 Nov 2022 | 4,050 | 906,550 | - | 1.0 | 4,127 | Common Stock |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 14 Nov 2022 | 1,000 | 907,550 | - | 1.0 | 950 | Common Stock |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 14 Nov 2022 | 150 | 907,700 | - | 1.0 | 149 | Common Stock |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 250,000 | 520,000 | - | - | Stock Options | |
| Immix Biopharma Inc | Ilya Rachman | Director, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 20 Dec 2021 | 2,500 | 902,500 | - | 5 | 12,500 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges